Biotech Startups

A medical device company developing orthopedic and biological solutions. Leadership includes experienced physicians, financial executives, and medical technology sales professionals.

2 investors

Aeromics is a clinical-stage pharmaceutical company developing AER-271, an intravenous aquaporin-4 (AQP4) inhibitor designed to prevent cerebral edema (brain swelling) following severe, acute ischemic stroke. Its approach targets molecular water channels to improve outcomes in neurological indications such as stroke, spinal cord injury, CNS surgery, and brain cancer.

2 investors

2 investors

Afyren produces bio-based organic acids derived from fermentation of non-food biomass to replace petroleum-derived molecules in consumer products and industrial applications. The company serves industrial manufacturers seeking alternatives to petrochemical ingredients across sectors including food, chemicals, and materials.

2 investors

AgTech Inventures is an agriculture technology innovation lab that develops intellectual property in agbiotech and precision agriculture, sourcing promising technologies from university research labs and small science-focused companies. It spins these technologies into new companies with input from industry partners, leading initial management teams and helping secure both non-dilutive and angel/venture financing.

2 investors

AGC Biologics is a contract development and manufacturing organization (CDMO) providing biopharmaceutical manufacturing services including cell therapy, mammalian, and mRNA-LNP production. The company operates multiple sites globally and is expanding its Japan capabilities with a new GMP-ready facility in Yokohama launching in 2027.

2 investors

AgroSustain develops biological, environmentally friendly crop protection solutions for pre- and post-harvest agricultural applications, helping protect plant health from field through harvest and supply chain. A University of Lausanne spin-off, it serves growers across four continents.

2 investors

Helical AI provides a virtual AI lab platform for drug discovery, tuning bio foundation models to a customer's own biology and orchestrating them into ranked, mechanistically grounded target and biomarker candidates. It is built for biopharma R&D teams, offering model-agnostic harnesses, therapeutically relevant benchmarking, and enterprise deployment without data lock-in.

2 investors

AI Proteins designs engineered miniproteins for drug discovery and development in the biopharmaceutical industry. The company uses artificial intelligence to create novel protein-based therapeutics with improved efficacy, safety, and manufacturability compared to naturally evolved proteins.

2 investors

Aignostics develops AI-powered pathology products and custom image and data analysis services for precision medicine and drug development, serving pharmaceutical and biomedical research teams. A spin-off from Charité Berlin, it works with academic and industry partners on tissue analysis validated by pathologists, from early drug discovery through regulated clinical applications.

2 investors

AION Labs is a venture studio founded by pharmaceutical companies (AstraZeneca, Pfizer, Merck, Teva) alongside AWS and venture capital partners to build and scale companies applying AI and emerging technologies to drug discovery and development. It provides founders with early pharma validation, R&D expertise, mentorship, and capital to accelerate the creation of solutions that address unmet needs in pharmaceutical innovation.

2 investors

AIRA is a platform that uses AI to support clinical development decision-making and study design for pharmaceutical and biotech companies. The company addresses inefficiencies in the drug development process by providing a unified, regulatory-grade system to help clinical teams design therapies faster and more safely.

2 investors

IQVIA Laboratories provides central laboratory and specialty biomarker services for drug discovery and development, serving pharmaceutical sponsors and clinical trial sites. Its offerings span bioanalytical, genomics, discovery sciences, vaccine, and digital lab technologies.

2 investors

Aitiologic is a molecular diagnostics and precision medicine company that uses AI-powered bioinformatics to translate disease biology into clinical insight. It operates in the biotech and diagnostics space.

2 investors

Ajax Health is a life science investment firm that manages a portfolio of medtech, biopharma, and diagnostic companies. The firm focuses on sourcing, due diligence, and active management of investments in the healthcare and medical technology sectors.

2 investors

Akamis Bio develops oncolytic immunotherapies for colorectal cancer treatment, aiming to offer alternatives to surgery that preserve patient function and quality of life. The company serves patients and clinicians in the oncology market.

2 investors

Akebia Therapeutics develops FDA-approved drug therapies for the treatment of kidney disease. The company is a fully integrated biopharmaceutical organization with a nephrology-focused commercial team and development capabilities.

2 investors

Akribion Therapeutics develops an RNA-guided, nuclease enzyme-based technology for programmable cell depletion using its G-dase E payload. The company initially targets HPV-induced oropharyngeal head and neck cancer (OPSCC) and is exploring further applications in precision oncology.

2 investors

A biopharmaceutical company (Ipsen, following its acquisition of Albireo Pharma) developing and commercializing medicines in oncology, rare diseases, and neuroscience for patients with high unmet medical needs. Its portfolio includes treatments for cancers, rare bone, liver, and neurogenetic disorders, and neurological conditions such as spasticity.

2 investors

Alcheme Bio develops precision enzyme systems that improve flavor and functionality in protein ingredients during manufacturing processing. The company's enzyme technology reduces off-notes and bitterness in plant proteins, upcycled materials, and emerging protein systems for food manufacturers.

2 investors

Alcresta Therapeutics develops enzyme-based therapeutic products to address nutritional care for enterally fed patients living with rare diseases. The company is based in Massachusetts and focuses on delivering novel enzymatic solutions within the biotechnology and pharmaceutical sector.

2 investors

Aldevron provides products and services for biotechnology research and life sciences discovery, operating as a subsidiary of Danaher to enable breakthrough scientific advances.

2 investors

Alethia Biotherapeutics is a clinical-stage biotechnology company developing cancer treatments that target tumor resistance by inhibiting the epithelial-mesenchymal transition (EMT) and remodeling the immunosuppressive tumor microenvironment. Its lead asset, sotevtamab, is a monoclonal antibody intended to be combined with standard therapies across multiple cancer indications.

2 investors

JRS is a family-owned company that manufactures and markets plant-based functional additives for food, pet food, pharmaceuticals, personal care, and technical applications globally. The group operates 3,000+ employees across 20+ international commercial entities, 7 R&D centers, and 50+ production facilities.

2 investors